Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 12 Mar 24 424B3 Prospectus supplement
- 1 Mar 24 424B3 Prospectus supplement
- 12 Feb 24 424B3 Prospectus supplement
- 1 Feb 24 424B3 Prospectus supplement
- 23 Jan 24 424B3 Prospectus supplement
- 22 Jan 24 EFFECT Notice of effectiveness
- 16 Jan 24 S-1/A IPO registration (amended)
- 10 Jan 24 UPLOAD Letter from SEC
- 8 Jan 24 S-1/A IPO registration (amended)
- 21 Dec 23 UPLOAD Letter from SEC
- 12 Dec 23 S-1/A IPO registration (amended)
- 19 Oct 23 UPLOAD Letter from SEC
-
5 Oct 23 S-1 IPO registration
CLDI similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
Calidi Biotherapeutics, Inc.
San Diego, California
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated March 31, 2023, relating to the financial statements of First Light Acquisition Group, Inc., which are contained in that Prospectus. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/S/ BDO USA, P.C.
New York, New York
October 5, 2023